Quay Pharma, now part of SGS, is a Contract Development and Manufacturing Organization (CDMO) with a strong focus on scientific expertise and flexibility. Established in 2002, Quay Pharma excels at responding to new challenges and ensuring the success of each project's clinical trials. With an exceptional depth of knowledge and experience, Quay Pharma offers bespoke solutions tailored to each client's individual requirements and circumstances.

Whether it's a university department researching new drug applications or a major manufacturer developing a new chemical entity, Quay Pharma has a proven track record of designing novel and effective drug delivery systems that meet client needs. Quay Pharma has successfully developed safe and robust products for over 100 clients, including hard-to-deliver New Chemical Entities, reformulations of established drugs, and generic products. Their expertise extends to medical devices and veterinary products as well.

Backed by a highly qualified team of scientists and state-of-the-art facilities, Quay Pharma provides a comprehensive range of services, from early-stage development to clinical trial supply and manufacturing. By joining forces with SGS, the world's leading testing, inspection, and certification company, Quay Pharma further strengthens its commitment to delivering quality and integrity in the pharmaceutical industry. Experience the scientific expertise and flexibility of Quay Pharma, now part of SGS, for your next drug development project